Photo Gallery

Pharma sales and marketing teams need to focus their resources where doctors want to engage, whether through in-person meetings, digital tactics or a combination of both. Whatever the approach, what message is being delivered—and how often—truly does matter. In this executive summary of the AccessMonitorTM and AffinityMonitorTM studies, ZS Principal Malcolm Sturgis shares the highlights of the latest research and offers useful insights about pharmaceutical companies’ sales and marketing interactions with healthcare providers.